BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36267001)

  • 21. Accuracy of a rapid glial fibrillary acidic protein/ubiquitin carboxyl-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury.
    Bazarian JJ; Welch RD; Caudle K; Jeffrey CA; Chen JY; Chandran R; McCaw T; Datwyler SA; Zhang H; McQuiston B
    Acad Emerg Med; 2021 Nov; 28(11):1308-1317. PubMed ID: 34358399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.
    Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP
    Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
    Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT;
    Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confounding factors of the expression of mTBI biomarkers, S100B, GFAP and UCH-L1 in an aging population.
    Calluy E; Beaudart C; Alokail MS; Al-Daghri NM; Bruyère O; Reginster JY; Cavalier E; Ladang A
    Clin Chem Lab Med; 2024 Apr; ():. PubMed ID: 38643415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Utility of Glial Fibrillary Acidic Protein Beyond 12 Hours After Traumatic Brain Injury: A TRACK-TBI Study.
    Puccio AM; Yue JK; Korley FK; Okonkwo DO; Diaz-Arrastia R; Yuh EL; Ferguson AR; Mukherjee P; Wang KKW; Taylor SR; Deng H; Markowitz AJ; Sun X; Jain S; Manley GT
    J Neurotrauma; 2024 Jun; 41(11-12):1353-1363. PubMed ID: 38251868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
    Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
    J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can serum biomarkers be used to rule out significant intracranial pathology in emergency department patients with mild traumatic brain injury? A Systemic Review & Meta-Analysis.
    Rogan A; O'Sullivan MB; Holley A; McQuade D; Larsen P
    Injury; 2022 Feb; 53(2):259-271. PubMed ID: 34763896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Are Not Specific Biomarkers for Mild CT-Negative Traumatic Brain Injury.
    Posti JP; Hossain I; Takala RS; Liedes H; Newcombe V; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
    J Neurotrauma; 2017 Jan; ():. PubMed ID: 27841729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploratory analysis of glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 in management of patients with mild neurological symptoms undergoing head computed tomography scan at the emergency department: a pilot study from a Croatian tertiary hospital.
    Lapić I; Rogić D; Lončar Vrančić A; Gornik I
    Lab Med; 2024 Feb; ():. PubMed ID: 38363974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating glial and neuronal blood biomarkers GFAP and UCH-L1 as gradients of brain injury in concussive, subconcussive and non-concussive trauma: a prospective cohort study.
    Papa L; Zonfrillo MR; Welch RD; Lewis LM; Braga CF; Tan CN; Ameli NJ; Lopez MA; Haeussler CA; Mendez Giordano D; Giordano PA; Ramirez J; Mittal MK
    BMJ Paediatr Open; 2019; 3(1):e000473. PubMed ID: 31531405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
    Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
    J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers May Predict Unfavorable Neurological Outcome after Mild Traumatic Brain Injury.
    Lewis LM; Papa L; Bazarian JJ; Weber A; Howard R; Welch RD
    J Neurotrauma; 2020 Dec; 37(24):2624-2631. PubMed ID: 32821007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury.
    Kobeissy F; Arja RD; Munoz JC; Shear DA; Gilsdorf J; Zhu J; Yadikar H; Haskins W; Tyndall JA; Wang KK
    Expert Rev Mol Diagn; 2024; 24(1-2):67-77. PubMed ID: 38275158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuronal Biomarker Ubiquitin C-Terminal Hydrolase Detects Traumatic Intracranial Lesions on Computed Tomography in Children and Youth with Mild Traumatic Brain Injury.
    Papa L; Mittal MK; Ramirez J; Silvestri S; Giordano P; Braga CF; Tan CN; Ameli NJ; Lopez MA; Haeussler CA; Mendez Giordano D; Zonfrillo MR
    J Neurotrauma; 2017 Jul; 34(13):2132-2140. PubMed ID: 28158951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomedical research brings mTBI biomarkers a step closer to the bedside - implementation in clinical practice.
    Martinikova M; Ruzinak R; Kurca E; Grey MT; Sivak S
    Gen Physiol Biophys; 2023 Jul; 42(4):323-338. PubMed ID: 37449317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concussion severity and functional outcome using biomarkers in children and youth involved in organized sports, recreational activities and non-sport related incidents.
    Papa L; Rosenthal K; Cook L; Caire M; Thundiyil JG; Ladde JG; Garfinkel A; Braga CF; Tan CN; Ameli NJ; Lopez MA; Haeussler CA; Mendez Giordano D; Giordano PA; Ramirez J; Mittal MK; Zonfrillo MR
    Brain Inj; 2022 Jul; 36(8):939-947. PubMed ID: 35904331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective Assessment of Acute Blood Markers of Brain Injury in Sport-Related Concussion.
    Meier TB; Nelson LD; Huber DL; Bazarian JJ; Hayes RL; McCrea MA
    J Neurotrauma; 2017 Nov; 34(22):3134-3142. PubMed ID: 28699381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.
    Mondello S; Papa L; Buki A; Bullock MR; Czeiter E; Tortella FC; Wang KK; Hayes RL
    Crit Care; 2011 Jun; 15(3):R156. PubMed ID: 21702960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
    Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O
    World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing blood biomarkers to clinical decision rules to select patients suspected of traumatic brain injury for head computed tomography.
    Li Y; Ding VY; Chen H; Zhu G; Jiang B; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
    Neuroradiol J; 2023 Feb; 36(1):68-75. PubMed ID: 35588232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.